Back to the main directory
EarningsReview / Equity
- Gjensidige Forsikring (Buy, TP: NOK150.00) - Solid capital position by DnB Markets
- NetEnt (Buy, TP: SEK55.00) - Support from new key customers by DnB Markets
- Covestro: More Conservative Scenario (TP €139), Valuation Remains Undemanding by Raymond James
- Brazilian catalyst still ahead by BNP Paribas Exane
- Alimak (Buy, TP: SEK155.00) - Back in order by DnB Markets
- Espresso | Euronav | Hold | 2018E back to the start, while we remain c. 100% above 2020 consensus by Kepler Cheuvreux
- TOWN: Maintain Outperform, but Lowering Target/Estimates; Thesis Largely Intact by Raymond James
- Espresso | Airbus | Hold | Solid Q3, uncertain FY 2018 guidance by Kepler Cheuvreux
- BioArctic (Buy, TP: SEK206.00) - CTAD 2018 update by DnB Markets
- Hexpol (Hold, TP: SEK87.00) - Our view remains intact by DnB Markets
- Investment Daily 26/10/2018 by BNP Paribas Exane
- Resilient Q3 despite no major launches in FY18e by BNP Paribas Exane
- ETH: Downgrading to Outperform With $23 Target; F2Q19 in Line With Pre-Release by Raymond James
- Orange - Q3 18: Results overshadowed by M&A chat (again) by New Street Research
- MPWR: Good Quarter, But We Don't Think It's Immune from Cyclical Concerns by Raymond James
- What the SRI investor should have read by BNP Paribas Exane
- YIT (Buy, TP: EUR6.40) - Keep the faith by DnB Markets
- Novo Nordisk (Buy, TP: DKK380.00) - Q3 set to see strong GLP-1 growth by DnB Markets
- Q318 results and 15 questions for management by BNP Paribas Exane
- Q3 18 in line: good margin thanks to Santos Barosa by BNP Paribas Exane
- Genco Shipping & Trading (Buy, TP: USD19.20) - Summer highs in its sights by DnB Markets
- NTGR: Strong 3Q Results; Cleaner Story Ahead; Maintain Outperform by Raymond James
- CBLK: 3Q Beat and Guide Above; Shift to Cloud Moving Ahead; Outperform by Raymond James
- Integrating APN Outdoor in our model by BNP Paribas Exane
- FSB: Maintain Market Perform but Reduce EPS Estimates on Lower but Stabilizing NIM by Raymond James
- AcadeMedia AB (Buy, TP: SEK75.00) - Clouded opportunity by DnB Markets
- Lundbeck (Hold, TP: DKK310.00) - LU35700 miss on primary endpoint by DnB Markets
- The story is repeated again by BNP Paribas Exane
- AVT: Solid Growth and Operational Execution; Maintain Strong Buy by Raymond James
- Espresso | Ferrovial | Hold | Counting on value crystallisation by Kepler Cheuvreux
- GILD: 3Q18 Results: Beat was an Anomaly; CEO Search/Filgotinib Commentary More Interesting by Raymond James
- Q3 18 warning: Asian volume impacted by price increases by BNP Paribas Exane
- Schibsted (Sell, TP: NOK260.00) - Q3 above with hiked guidance by DnB Markets
- SKF (Buy, TP: SEK180.00) - Cost inflation on the way by DnB Markets
- Chasing input costs by BNP Paribas Exane
- Spectrum (Sell, TP: NOK36.00) - 2019 consensus remains too high by DnB Markets
- Softer Q3; tone generally positive on market backdrop by BNP Paribas Exane
- THFF: Maintain Market Perform Following a Steady as She Goes Quarter by Raymond James
- ATNI: Market Perform Maintained, as Value Remains on Balance Sheet by Raymond James
- CMG: EPS Beat on Margins, Traffic Remains Sluggish; '19 Estimates Below Street; Reit. Market Perform by Raymond James
- Close to an all-time low share price by BNP Paribas Exane
- Seafood - The Fat Trout Weekly by DnB Markets
- ARLO: Solid 3Q Results; 4Q Growth and Margin to Step Down; Maintain Market Perform by Raymond James
- SWK: 3Q "Above The Line" Results Miss Street Estimates, As Does Guidance by Raymond James
- AAL: Execution Key to Overcoming Optics Hurdle by Raymond James
- Safe Bulkers (Buy, TP: USD3.80) - 3.3x P/E for 2019e by DnB Markets
- Provision releases help the bottom line by BNP Paribas Exane
- FLEX: A Perfect Storm Hits Flex; Maintain Market Perform by Raymond James
- Oncopeptides (Buy, TP: SEK247.00) - Waiting for ASH meeting by DnB Markets
- Second peak Q3 results week by DnB Markets